Phase-II study of high-dose thiotepa, melphalan and carboplatin (TMCb) with autologous peripheral blood stem cell (PBSC) support in patients with hematologic malignancies and solid tumors.

被引：0
|
作者：
Demirer, T
Ilhan, O
Ayli, M
Arat, M
Fen, T
Haznedar, R
Ozcan, M
Arslan, O
Gurman, G
Akan, H
Dagli, M
Konuk, N
Yildiz, M
Ozet, G
Uysal, A
Koc, H
机构：
[1] Ankara Univ, Sch Med, Dept Hematol, TR-06100 Ankara, Turkey
[2] Ankara Numune Hosp, Bone Marrow Transplant Unit, Ankara, Turkey
[3] Ankara Oncol Hosp, Dept Hematol, Ankara, Turkey
[4] Gazi Univ, Sch Med, Dept Hematol, Ankara, Turkey
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5344
引用
收藏
页码：368B / 368B
页数：1
相关论文
共 50 条
  • [1] High-dose Thiotepa, Melphalan and Carboplatin (TMCB) with autologous Peripheral Blood Stem Cell (PBSC) support in patients with hematologic malignancies and solid tumors
    Demirer, T
    Ilhan, O
    Ayli, M
    Arat, M
    Fen, T
    Ozcan, M
    Arslan, O
    Gurman, G
    Akan, H
    Konuk, N
    Ozet, G
    Uysal, A
    Koc, H
    [J]. BONE MARROW TRANSPLANTATION, 2001, 27 : S336 - S336
  • [2] A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies
    T Demirer
    O lhan
    NM Mandel
    M Arat
    N Günel
    H Çelebi
    C Üstün
    H Akan
    S Demirer
    S Aydıntuğ
    A Uysal
    H Koç
    [J]. Bone Marrow Transplantation, 2000, 25 : 697 - 703
  • [3] A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies
    Demirer, T
    Ilhan, O
    Mandel, NM
    Arat, M
    Günel, N
    Çelebi, H
    Üstün, C
    Akan, H
    Demirer, S
    Aydintug, S
    Uysal, A
    Koc, H
    [J]. BONE MARROW TRANSPLANTATION, 2000, 25 (07) : 697 - 703
  • [4] High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation in patients with lymphoma - a retrospective evaluation
    Demirer, T
    Ayli, M
    Fen, T
    Ozcan, M
    Arat, M
    Buyukberber, S
    Arslan, O
    Gurman, G
    Akan, H
    Ilhan, O
    [J]. BONE MARROW TRANSPLANTATION, 2004, 34 (09) : 781 - 786
  • [5] High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation in patients with lymphoma – a retrospective evaluation
    T Demirer
    M Ayli
    T Fen
    M Ozcan
    M Arat
    S Buyukberber
    O Arslan
    G Gurman
    H Akan
    O Ilhan
    [J]. Bone Marrow Transplantation, 2004, 34 : 781 - 786
  • [6] Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant disease
    Schiffman, KS
    Bensinger, WI
    Appelbaum, FR
    Rowley, S
    Lilleby, K
    Clift, RA
    Weaver, CH
    Demirer, T
    Sanders, JE
    Petersdorf, S
    Gooley, T
    Weiden, P
    Zuckerman, N
    Montgomery, P
    Maziarz, R
    Klarnet, JP
    Rivkin, S
    Trueblood, K
    Storb, R
    Holmberg, L
    Buckner, CD
    [J]. BONE MARROW TRANSPLANTATION, 1996, 17 (06) : 943 - 950
  • [7] High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous stem cell transplantation in patients with advanced breast cancer: a retrospective evaluation
    Demirer, T
    Ayli, M
    Ilhan, O
    Koc, H
    Dagli, M
    Arat, M
    Fen, T
    Dincer, S
    Ozet, G
    Akan, H
    Uysal, A
    [J]. BONE MARROW TRANSPLANTATION, 2003, 31 : S195 - S196
  • [8] High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous stem cell transplantation in patients with advanced breast cancer: a retrospective evaluation
    T Demirer
    V A Uysal
    M Aylı
    Y Genc
    O Ilhan
    H Koc
    M Daglı
    M Arat
    N Gunel
    T Fen
    S Dincer
    N Ustael
    M Yildiz
    T Ustun
    E Seyrek
    G Ozet
    O Muftuoglu
    H Akan
    [J]. Bone Marrow Transplantation, 2003, 31 : 755 - 761
  • [9] High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous stem cell transplantation in patients with advanced breast cancer: a retrospective evaluation
    Demirer, T
    Uysal, VA
    Ayli, M
    Genc, Y
    Ilhan, O
    Koc, H
    Dagli, M
    Arat, M
    Gunel, N
    Fen, T
    Dincer, S
    Ustael, N
    Yildiz, M
    Ustun, T
    Seyrek, E
    Ozet, G
    Muftuoglu, O
    Akan, H
    [J]. BONE MARROW TRANSPLANTATION, 2003, 31 (09) : 755 - 761
  • [10] High-dose thiotepa, melphalan and carboplatin followed by autologous peripheral blood stem cell transplantation in patients with lymphoma - a retrospective evaluation
    Demirer, T
    Soydan, E
    Fen, T
    Ilhan, O
    Ayli, M
    Arat, M
    Ozcan, M
    Gunel, N
    Arslan, O
    Genc, Y
    Uysal, A
    Haznedar, R
    Buyukberber, S
    Gurman, G
    Ustaer, N
    Hazar, B
    Ozet, G
    Akan, H
    [J]. BONE MARROW TRANSPLANTATION, 2004, 33 : S250 - S250
12345